Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | JBZ-001 |
Synonyms | |
Therapy Description |
JBZ-001 inhibits DHODH, which blocks the de novo pyrimidine biosynthesis pathway and potentially inhibits tumor growth (PMID: 38646934). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
JBZ-001 | HOSU-53|JBZ 001|JBZ001|HOSU53|HOSU 53 | JBZ-001 inhibits DHODH, which blocks the de novo pyrimidine biosynthesis pathway and potentially inhibits tumor growth (PMID: 38646934). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT06801002 | Phase I | JBZ-001 | Trial to Evaluate the Safety & Tolerability of JBZ-001 in Pts With Advanced Solid and Hematological Malignancies | Recruiting | USA | 0 |